Education
Education, Environment, Economics Icons

Covid booster

Share:

As of October 2021, more than 6.4 million doses of the COVID-19 vaccine booster have been administered across the United States.

Although an individual who has received two full doses of the Pfizer-BioNTech is considered fully vaccinated, a booster shot is recommend to lessen possible illness, hospitalization, death, and other long term health effects against the COVID-19 Delta variant. Currently, the following populations already vaccinated with the Pfizer vaccine should or may consider receiving a booster shot:

– Older adults and 50-64 years old people with medical conditions should

– Long-term care setting residents aged 18 years and older may

– People with medical conditions aged 18-49 years may

– Employees and residents at increased risk for COVID-19 exposure and transmission may

 

​Produced, additional populations may be recommended to receive the booster shot. Booster shot symptoms remain similar to those potentially experienced during the 2-shot series. The intent of the booster vaccine was initiated to induce long-lasting protection.

So, if your personal verdict is still out and you are in one of the booster eligible populations, you should consider getting the booster at least six months after the two shot Pfizer series. However, if you are not in one of eligible populations then continue to operate under the current CDC precautions until additional guidance is provided.

Sources:

https://ourworldindata.org/covid-vaccinations?country=OWID_WRL#how-many-vaccine-booster-doses-have-been-administered

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html#BoosterShotvsAdditionalDose

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html

https://www.cdc.gov/media/releases/2021/p0924-booster-recommendations-.html

 

Related Posts

The American Heart Association is continuously working to reduce the impact of the coronavirus.

Dr. Kizzmekia Corbett is an American viral immunologist. She is an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and the Shutzer Assistant

Get the Uzima Newsletter